We are monitoring the impact of COVID-19 on North America Transfection Reagents And Equipment Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 3087
Share on
Share on

North America Transfection Reagents And Equipment Market Research Report - Segmented By Product, By Method, By Application, By End User & By Country(U.S, Canada and Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2019-2024

Pulished: August, 2019
ID: 3087
Pages: 178

North America Transfection Reagents and Equipment Market Size & Growth (2019 - 2024)

As per the research report, the size of the North America Transfection Reagents and Equipment Market size is valued at USD 248.02 million in 2019. It is estimated to grow at a CAGR of 7.6 % to reach USD 357.72 million by 2024 during the forecast period 2019-2024. It is the largest market globally capturing a market share of 30%.

The process which involves the insertion of genetic material, for example, DNA and RNA (double-stranded), into mammalian cells is called transfection. Substances containing the genetic material are called transfection reagents and the equipment is usually used as a delivery mechanism.

Technological advancements occurring in the transfection reagents and equipment market in recent years has addressed the needs of researchers along with biotechnology & biopharmaceutical companies. High-efficiency transfection instruments have entered the market because of these advancements. Further, efficient quantitative and qualitative transfection in a wide range of cells, encompassing the hard-to-transfect cells are also the result of the technological advances.

Alliances worldwide between the pioneering research institutes to trigger drug discovery, technological advancements in transfections, research activities by pharmaceutical and biotechnology companies coupled with augmented research and development spending, an increasing number of cases of cancer and rise in demand for synthetic genes are driving the growth of this market.

Homebrew reagents by researchers, selective effectiveness of transfection reagents as well as the hefty costs of transfection reagents are the primary factors expected to slow down the growth of this market.

This research report segmented and sub-segmented into the following categories:

  • By Product: Reagents, Instruments     
  • By Method: Biochemical, Calcium Phosphate, Physical, Viral  
  • By Application: Biomedical Research, Protein Production, Therapeutic Delivery           
  • By End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies  
  • By Country: U.S, Canada and Rest of North America

In 2016, the academic & research institutes category is likely to command the largest market share. Although, the pharmaceutical & biotechnologies category is estimated to grow at the highest CAGR during the aforementioned forecast period.

Presently, North America accounts for the largest market share. The US is the leading market in North America.

Companies playing a dominant role in the North America Transfection Reagents and Equipment Market profiled in this report are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands). These companies hold a leading position in the transfection reagent and equipment market because of their well-established presence in the fields of genomics, spanning fifty countries, heavy R&D investments, and strong sales as well as distribution force. Other players in the market include Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).

1.Introduction         

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary

                3.2 Key Inferences

                3.3 Epidemology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Product        

                                5.1.1 Reagents                                 

                                5.1.2 Instruments                                           

                                5.1.3  Y-o-Y Growth Analysis, By Product                                              

                                5.1.4  Market Attractiveness Analysis, By Product                                            

                                5.1.5  Market Share Analysis, By Product                                              

                5.2 Method      

                                5.2.1 Biochemical                                            

                                5.2.2 Calcium Phosphate                                              

                                                5.2.2.1 Lipofection                          

       5.2.2.1.1 Advantages     

       5.2.2.1.2 Disadvantages

                                                5.2.2.2 Calcium Phosphate                          

       5.2.2.2.1 Advantages     

       5.2.2.2.2 Disadvantages

                                                5.2.2.3 DEAE-dextran                    

       5.2.2.3.1 Advantages     

       5.2.2.3.2 Disadvantages

                                                5.2.2.4 Dendrimers                         

       5.2.2.4.1 Advantages     

       5.2.2.5.1 Disadvantages

                                5.2.3 Physical                                    

                                                5.2.3.1 Electroporation                 

       5.2.3.1.1 Advantages     

       5.2.3.1.2 Disadvantages

                                                5.2.3.2 Nucleofection                    

       5.2.3.2.1 Advantages     

       5.2.3.2.2 Disadvantages

                                                5.2.3.3.Others                  

       5.2.3.3.1 Sonoporation 

       5.2.3.3.2 Genegun          

                       5.2.3.3.2.1 Advantages

                       5.2.3.3.2.2 Disadvantages

       5.2.3.3.3 Magnetofection            

                       5.2.3.3.3.1 Advantages

                       5.2.3.3.3.2 Disadvantages

       5.2.3.3.4 Optoinjection 

                       5.2.3.3.4.1 Advantages

                       5.2.3.3.4.2 Disadvantages

                                5.2.4 Viral                                           

                                                5.2.4.1 Adenoviruses                     

                                                5.2.4.2 Retroviruses                       

                                                5.2.4.3 Adenoassociated Viruses (AAV)                

                                5.2.5 Y-o-Y Growth Analysis, By Method                                              

                                5.2.6 Market Attractiveness Analysis, By Method                                            

                                5.2.7 Market Share Analysis, By Gimmick                                             

                5.3 Application 

                                5.3.1 Biomedical Research                                           

                                                5.3.1.1 Gene Expression Studies                              

                                                5.3.1.2 Cancer Research                               

                                                5.3.1.3 Transgenic Model                             

                                5.3.2 Protein Production                                              

                                5.3.3 Therapeutic Delivery                                          

                                5.3.4 Y-o-Y Growth Analysis, By Application                                         

                                5.3.5  Market Attractiveness Analysis, By Application                                      

                                5.3.6  Market Share Analysis, By Application                                       

                5.4 End User      

                                5.4.1 Academic & Research Institutes                                    

                                5.4.2 Pharmaceutical & Biotechnology Companies                                           

                                5.4.3 Y-o-Y Growth Analysis, By End User                                             

                                5.4.4  Market Attractiveness Analysis, By End User                                          

                                5.4.5  Market Share Analysis, By End User                                            

6. Geographical Analysis                     

                6.1 Introduction      

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Product                           

                                                6.1.3.3 By Method                         

                                                6.1.3.4 By Application                    

                                                6.1.3.5 By End User                        

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Product                           

                                                6.1.4.3 By Method                         

                                                6.1.4.4 By Application                    

                                                6.1.4.5 By End User                        

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Product                           

                                                6.1.5.3 By Method                         

                                                6.1.5.4 By Application                    

                                                6.1.5.5 By End User                        

                6.2 United States   

                6.3 Canada         

7.Strategic Analysis               

                7.1 PESTLE analysis

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis     

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                

                8.1 Thermo Fisher Scientific Inc. (U.S.)   

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Promega Corporation (U.S.)

                8.3 Hoffmann-La Roche Ltd. (Switzerland)  

                8.4 QIAGEN N.V. (Netherlands)

                8.5 Polyplus-transfection SA (France)    

                8.6 Bio-Rad Laboratories (U.S.)

                8.7 Lonza Group (Switzerland)  

                8.8 Sigma-Aldrich Corporation (U.S.)      

                8.9 Mirus Bio LLC (U.S.)

                8.10 MaxCyte Inc. (U.S.)     

9.Competitive Landscape                   

                9.1 Market share analysis            

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of method, Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Transfection Reagents and Equipment Market By Product, From 2019-2024 ( USD Million )
  2. North America Reagents Market By Region, From 2019-2024 ( USD Million )
  3. North America Instruments Market By Region, From 2019-2024 ( USD Million )
  4. North America Transfection Reagents and Equipment Market By method, From 2019-2024 ( USD Million )
  5. North America Biochemical Market By Region, From 2019-2024 ( USD Million )
  6. North America Calcium Phosphate Market By Region, From 2019-2024 ( USD Million )
  7. North America Lipofection Market By Region, From 2019-2024 ( USD Million )
  8. North America DEAE-dextran Market By Region, From 2019-2024 ( USD Million )
  9. North America Dendrimers Market By Region, From 2019-2024 ( USD Million )
  10. North America Physical Market By Region, From 2019-2024 ( USD Million )
  11. North America Electroporation Market By Region, From 2019-2024 ( USD Million )
  12. North America Nucleofection Market By Region, From 2019-2024 ( USD Million )
  13. North America Others Market By Region, From 2019-2024 ( USD Million )
  14. North America Viral Market By Region, From 2019-2024 ( USD Million )
  15. North America Transfection Reagents and Equipment Market By Application, From 2019-2024 ( USD Million )
  16. North America Biomedical Research Market By Region, From 2019-2024 ( USD Million )
  17. North America Gene Expression Studies Market By Region, From 2019-2024 ( USD Million )
  18. North America Cancer Research Market By Region, From 2019-2024 ( USD Million )
  19. North America Transgenic Model Market By Region, From 2019-2024 ( USD Million )
  20. North America Protein Production Market By Region, From 2019-2024 ( USD Million )
  21. North America Therapeutic Delivery Market By Region, From 2019-2024 ( USD Million )
  22. North America Transfection Reagents and Equipment Market By End User, From 2019-2024 ( USD Million )
  23. North America Academic & Research Institutes Market By Region, From 2019-2024 ( USD Million )
  24. North America Pharmaceutical & Biotechnology Companies Market By Region, From 2019-2024 ( USD Million )
  25. United States Transfection Reagents and Equipment Market By Product, From 2019-2024 ( USD Million )
  26. United States Transfection Reagents and Equipment Market By method, From 2019-2024 ( USD Million )
  27. United States Transfection Reagents and Equipment Market By Application, From 2019-2024 ( USD Million )
  28. United States Transfection Reagents and Equipment Market By End User, From 2019-2024 ( USD Million )
  29. Canada Transfection Reagents and Equipment Market By Product, From 2019-2024 ( USD Million )
  30. Canada Transfection Reagents and Equipment Market By method, From 2019-2024 ( USD Million )
  31. Canada Transfection Reagents and Equipment Market By Application, From 2019-2024 ( USD Million )
  32. Canada Transfection Reagents and Equipment Market By End User, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample